Associated Genetic Biomarkers
NCI Definition: A rare, aggressive malignant mesenchymal neoplasm that arises from the ovary. The prognosis is poor. 
There are 2 clinical trials for ovarian sarcoma, of which 2 are open and 0 are completed or closed. Of the trials that contain ovarian sarcoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 2 (1 open).
HLA-A*02:01 is the most frequent gene inclusion criterion for ovarian sarcoma clinical trials .
Aldesleukin, cyclophosphamide, and decitabine are the most common interventions in ovarian sarcoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.